Yocca Frank Insider Trades

Insider Trading History

Track insider trading activity for Yocca Frank. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Scientific Officer
Holding Value $34.3k 26,210 shares
Last Trade
Jun 15, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$40.6 35 shares
$1.16
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Scientific Officer
Holding Value $278 212 shares
Last Trade
Jun 15, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$40.6 35 shares
$1.16
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Scientific Officer
Holding Value $34.3k 26,175 shares
Last Trade
May 20, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$7.46k 6,845 shares
$1.09
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Scientific Officer
Holding Value $43.3k 33,020 shares
Last Trade
May 04, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$22.1k 17,500 shares
$1.26
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Scientific Officer
Holding Value $68.8k 52,500 shares
Last Trade
May 04, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$22.1k 17,500 shares
$1.26
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Scientific Officer
Holding Value $0 0 shares
Last Trade
May 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$10.8k 9,000 shares
$1.20
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Scientific Officer
Holding Value $20.3k 15,520 shares
Last Trade
May 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$10.8k 9,000 shares
$1.20
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Scientific Officer
Holding Value $8.54k 6,520 shares
Last Trade
Mar 15, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$52.2 35 shares
$1.49
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Scientific Officer
Holding Value $324 247 shares
Last Trade
Mar 15, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$52.2 35 shares
$1.49
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Scientific Officer
Holding Value $8.5k 6,485 shares
Last Trade
Mar 14, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$49.2 33 shares
$1.49
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Scientific Officer
Holding Value $127 97 shares
Last Trade
Mar 14, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$49.2 33 shares
$1.49
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Scientific Officer
Holding Value $92.1k 70,282 shares
Last Trade
Jan 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$112k 70,000 shares
$1.60
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Scientific Officer
Holding Value $8.45k 6,452 shares
Last Trade
Dec 15, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$65.6 35 shares
$1.88
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Scientific Officer
Holding Value $369 282 shares
Last Trade
Dec 15, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$65.6 35 shares
$1.88
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Scientific Officer
Holding Value $8.41k 6,417 shares
Last Trade
Dec 14, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$66.3 33 shares
$2.01
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Scientific Officer
Holding Value $170 130 shares
Last Trade
Dec 14, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$66.3 33 shares
$2.01
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Scientific Officer
Holding Value $8.36k 6,384 shares
Last Trade
Sep 15, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$111 35 shares
$3.17
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Scientific Officer
Holding Value $415 317 shares
Last Trade
Sep 15, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$111 35 shares
$3.17
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Scientific Officer
Holding Value $214 163 shares
Last Trade
Sep 14, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$103 33 shares
$3.11
$1.31
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Chief Scientific Officer
Holding Value $8.32k 6,349 shares
Last Trade
Sep 14, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$103 33 shares
$3.11
$1.31

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up